FreedomWorks Foundation's Regulatory Action Center (RAC) submitted formal written comments to the Food and Drug Administration (FDA) to oppose their proposed rule concerning the labeling of dairy alternatives. This rule would be an infringement on the First Amendment rights of businesses across America by essentially banning the use of phrases such as "almond milk" in commercial use. The full text of our comments can be found below or in the attachment at the bottom of the piece:

In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it without imposing price controls.